We developed methods to assess the cancer risks by screening tests. These methods estimate the size of the high risk group adjusted for the characteristics of screening tests and estimate the incidence rates of cancer among the high risk group adjusted for the characteristics of the tests. A method was also developed for selecting the cut-off point of a screening test. Finally, the methods were applied to estimate the risk of the adult T-cell leukemia/lymphoma.
Introduction
The characteristics of a screening test are usually expressed by sensitivity and specificity. The sensitivity (specificity) of a test is the probability that a person having (not having) the disease is correctly classified.
The prevalence rate of cancer is frequently estimated through the use of a screening test. The effects of the characteristics of the test in estimating disease rates have been investigated and methods are proposed for adjusting the disease rates (1, 2) with the characteristics of the test assumed to be known. Methods of estimating the characteristics of the test have also been developed by several authors. Tanenbein (3) considered the use of a double sampling scheme. Hochberg (4) extended this to provide a basis for inference from general multidimensional contingency tables. Goldberg and Wittes (5) applied the capture-recapture model. Hui and Walter (6) suggested that data are available from any two populations with different prevalences and applied the method of maximum likelihood in estimating simultaneously the characteristics of the test and the prevalence rates in both populations. Yanagawa et al. (7) and Yanagawa and Kasagi (8) introduced a study design in which a person is tested repeatedly at least three different times, and they developed a method of estimating prevalence and incidence rates of disease together with the characteristics of a test. Recently the variance of an estimator of the test characteristics was studied (9) .
In this paper we consider cancers such as those caused by virus, genetic factors, and the like. The group that is infected by the virus or that inherits the genetic factors is called the high risk group. We used the situation where a screening test is employed to judge whether or not a person belongs to the high risk group. Also we determine the situation where a person is diagnosed positive (negative), if and only if the response of the test exceeds (does not exceed) the predetermined value. The value is called the cut-off point.
We first proposed a method to determine the cut-off point of the screening test. The point is determined in such a way to estimate the characteristics of the test and select the point that minimizes the estimated bias in estimating the prevalence rate. Next we developed a method of estimating the size of the high risk group in a population that adjusts for the characteristics of the screening test. The method is an extension of that proposed in Yanagawa and Tokudome (10) . We next developed a method of estimating the incidence rates of cancer among the high risk group. The method adjusts for the characteristics of the screening test. There are extensive studies on this topic (11) (12) (13) (14) (15) (16) , but they do not discuss the characteristics of screening tests. These studies assume two binomial variates. An excellent review of these methods are given by Gart and Num (16) . On the other hand, the estimation of the risk ratio is developed by Gart (17) 
where P0 stands for the true prevalence rate. Therefore, the relative bias which will be introduced by test 2 with cut-off point ci is:
Relative bias = {Pi -P0 I/PO = jai -PO(ai + Ii)IIPo (3) Note that the usual method does not necessarily lead to the cut-off point that minimize this bias, even if test 1 is the perfect test (a = i = 0), since impact of a is stronger than P in estimating the prevalence rate (2). Furthermore, note that if PO is small, the a and P that minimize Eq. (3) also minimize the mean square errors when the frequency is employed in estimating PO.
We need estimates of PO, a, P and ai and Pi, i = 1, 2,..., r + 1 to assess the bias given in Equation (3). We now describe it by considering the data expressed in Table 1 . The total number of the parameters involved in it is 3 + 2(r + 1) = 2r + 5, but there is only 2r +
( Confidence Interval for j,u Let P again be the probability of a person diagnosed to be positive by the screening test. Let X and Z be independent binomial variates based on sample sizes n and N and parameters P and wr, respectively. We consider the confidence interval of L,, when nP and NIT are not large in a situation where the Poisson approximation to the binomial distribution is appropriate. The approximation has been employed in Gart (17) (6) [{N n n(l -at-0p)2 P] where u is the estimated cancer incidence rate in HI, and Za is as defined in Eq. (4), and P = x/n. where -a) (4) If the value of P is small, say 0.05, then Eq. (6) shows that a should be extremely small, otherwise the confidence limits inflate and estimation ofthe risk ratio looses its validity. Note that Rogan and Gladen (1) given by the following procedure:
Step 1: Give an initial estimate of po.
Step 2 where
Step 3: Obtain z.
'o = L NiPoi
Step 4: Repeat Step 1-Step 3 until convergence. An approximate 100(1-alpha)% confidence limit of Ro is given by:
Ilo ±+ Za [RVZ] Application to Estimating Risk of ATLL
The adult T-cell leukemia/lymphoma (ATLL) is the disease proposed recently (18) . The disease is caused by retrovirus termed human T-lymphotropic virus type I (HTLV-I). The disease is endemic in Japan and is contracted from HTLV-I carriers. The virus may be transmitted from mother to child and between husband and wife. Further studies have shown that HTLV-I can be transmitted by blood transfusion. The authors were involved in the project of estimating the risk of ATLL in Saga prefecture in Kyushu. The high risk group of the malignant neoplasm in this study is the one with HTLV-I carriers. The cases of ATLL were obtained from the cancer registry and also from related records in the prefecture. The number of the carriers is estimated by the examination of the sera of blood donors. It is important to study the bias that might have been introduced by the use of donor's blood, but we could not quantify it for various practical reasons. The epidemiologic results of the whole study are published elsewhere (19) .
Selecting the Cut-off Point
The anti-adult T-cell leukemia/lymphoma-associated antigen (ATLA) of serum has been examined in the laboratory by an indirect immunofluorescence (IF) test using acetone-fixed MT-1 cells on slides as ATLA (20) . When IF dilution of serum of 1:5 or higher gives a positive immunofluorescence, the serum is judged to be IgG anti-ATLA-positive. A simple and sensitive gelatin particle agglutination (PA) procedure has been developed for mass screening of the antibody to HTLV-I in human sera. The procedure in the PA test is much simpler than that in the IF test or in enzyme-linked immunosorbent assays (ELISA) because it involves only a one-step reaction of antigen and antibody, whereas more steps are required in the other tests. The titer of the antibody in the PA test is expressed as the reciprocal ofthe greatest serum dilution that gives positive reactions.
Several authors (21) suggest selecting 24 as the cutoff point of the titer in the PA test, namely to judge the final serum dilution of 1:24 or higher showing agglutination as positive. We examine this cut-off point based on the data in Table 2 , which are given by Kamihira et al. (22) . The data have been collected in a different sampling scheme, but the results in previous papers (21, 23 Table 2 lists the results of 19,816 sera tested by both tests. The two estimates of the parameters from Table 2 that were obtained by assuming the perfection of the IF test and the restriction previously described above, respectively, are shown to be identical in these data; these estimates are listed in Table 8 together with the relative bias obtained from Eq. (3). The table shows that when 24 is selected as the cut-off point, the bias is 0.123; when 26 is selected, the bias is 0.007, which is the smallest among the four. Table 6 lists the number of cases of ATLL for 3 years and also shows the population in Saga prefecture between the ages of 30 to 60. No cases of ATLL are reported in ages 20 to 40 in males and age 20 to 30 in females. Table 6 also lists the estimates of the incidence rates of ATLL among the HTLV-I carriers in males and females and its summary rates. The estimates are obtained by the method developed in the text. It was supposed that a = 0.00053, p = 0.01784 are known constants. To study the impact of the characteristics of the test, estimates were obtained for several values of a and , in females based on the data in Tables 4 and 6. The estimates are summarized in Table 7 . The table shows substantial impact for large values of a. Since there is no incidence of ATLL for the group ages 20 to 30 on which the impact is the greatest, as was discussed previously, the table shows that the impact of the characteristics of the screening test on the summary risk ratio is not so strong as the estimation of the size of the carriers. Note that if the values of a exceed 0.032, the 
